Oxalic Acid

Oxalic Acid

SCHEMBL14908944

CN(C)C(=O)[C@H]1CC[C@H](N)[C@H](NC(=O)O)C1.O.O=C(O)C(=O)O

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.32
▸ MME P08473 2/20 0.31
▸ FASN P49327 1/20 0.31
▸ PDE7A Q13946 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL4114848 0.98 MME (0.32) DPP4MMEFASNPDE7A
SCHEMBL27903631 0.95 MME (0.33) DPP4MMEFASNPDE7A
SCHEMBL1503908 0.95 MME (0.33) DPP4MMEFASNPDE7A
Sulfuric Acid SCHEMBL17472893 0.90 MME (0.31) MMEFASN
SCHEMBL20293628 0.84 MME (0.34) DPP4MMEFASNPDE7A
SCHEMBL20293481 0.84 MME (0.34) DPP4MMEFASNPDE7A
SCHEMBL31444622 0.84 BTK (0.36) —
SCHEMBL20328936 0.83 FASN (0.38) MMEFASN
Oxalic Acid SCHEMBL29538921 0.81 BTK (0.46) —
Water SCHEMBL14908947 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809546-B2 Process for producing diamine derivative Chungwha Chemical Synthesis & Biotech Co., Ltd. (TW) 2017-11-07 — — US disclosed
US-20170260138-A1 PROCESS FOR PRODUCING DIAMINE DERIVATIVE CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. LTD. (TW) 2017-09-14 — — US disclosed
EP-2589590-B1 PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT DAIICHI SANKYO CO LTD (JP) 2016-12-28 — — EP disclosed
US-8901345-B2 Process for preparation of optically active diamine derivative salt DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-12-02 — — US disclosed
US-20130165657-A1 PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-06-27 — — US disclosed
EP-2589590-A1 PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-05-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165657-A1 PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT TFPI, F12, TFPI2 DPP4 363/4885MME 443/4885FASN 4407/4885
US-20170260138-A1 PROCESS FOR PRODUCING DIAMINE DERIVATIVE DDT, ODC1, DDC DPP4 1290/4885MME 1255/4885FASN 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback